The Finlay Institute of Vaccines (IFV) announced this Wednesday that the Cuban drug Sovereign Plus came to Belarus to support immunization in that country against the COVID-19according to official media on the Island.
Through its Twitter account, the scientific entity stated that the regulatory agency of that nation also registered the vaccine for use. sovereign 02another of the drugs designed by IFV against the SARS-Cov-2 virus, according to a note published by the official newspaper Granma.
#Last News
The website of the Ministry of Health of Belarus publishes today two news of interest: 1) The arrival in the country of our vaccine #SovereignPlus for the treatment of the Belarusian population, and 2) Registration by its Regulatory agency of the #sovereign02#CubanScience pic.twitter.com/vg5e8Wcs9T— Finlay Vaccine Institute (@FinlayInstituto) October 12, 2022
The Ministry of Health of Belarus, quoted by the newspaper, he explained that all the vaccines that have been registered and authorized for use in the country are highly effective and safe immunobiological drugs.
Last February, Juan Valdés Figueroa, Ambassador of Cuba in Belarus, presented in Minsk the three Cuban anti-COVID-19 vaccines developed up to that time. The incident occurred during a meeting at the Center for Medical Examinations and Expertise (CEPM).
In July, several Belarusian institutions and the BioCubaFarma Business Group signed a memorandum of understanding for the scientific-technological development of both countries.
The purpose of this agreement is to promote mutual exchange in the field of promotion, investment, production, services and research in areas and products of interest to the pharmaceutical and biotechnological Belarusian and Cuban.
Several Cuban products developed at the CIGB are already registered in the Eurasian nation, such as Leucocim (filgrastim), Heberprot-P (recombinant human epidermal growth factor) and EPOCIM (a drug based on recombinant human erythropoietin type alpha ).
The vaccines against COVID-19 developed in Cuba are used in countries such as IranVenezuela, Vietnam and Nicaragua. Recently, the president of Mexico, Andres Manuel López Obrador, announced that his country acquired 9 million doses of the Abdala vaccineas part of an agreement on public health signed between Cuba and the Central American nation.
According to the data revealed so far, Cuban anti-COVID-19 vaccines have been more than 90% effective, but none have so far received the approval of the World Health Organization (WHO).
